BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Parfrey PS, Foley RN, Wittreich BH, Sullivan DJ, Zagari MJ, Frei D. Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. J Am Soc Nephrol. 2005;16:2180-2189. [PMID: 15901766 DOI: 10.1681/asn.2004121039] [Cited by in Crossref: 256] [Cited by in F6Publishing: 77] [Article Influence: 15.1] [Reference Citation Analysis]
Number Citing Articles
1 Plantinga LC, Fink NE, Jaar BG, Huang IC, Wu AW, Meyer KB, Powe NR. Relation between level or change of hemoglobin and generic and disease-specific quality of life measures in hemodialysis. Qual Life Res 2007;16:755-65. [PMID: 17286191 DOI: 10.1007/s11136-007-9176-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
2 Kovesdy CP, Kalantar-Zadeh K. Review article: Biomarkers of clinical outcomes in advanced chronic kidney disease. Nephrology (Carlton) 2009;14:408-15. [PMID: 19563383 DOI: 10.1111/j.1440-1797.2009.01119.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
3 Foley RN, Curtis BM, Parfrey PS. Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: a randomized trial. Clin J Am Soc Nephrol 2009;4:726-33. [PMID: 19339412 DOI: 10.2215/CJN.04950908] [Cited by in Crossref: 45] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
4 Lo WK. Latest Strategy in Renal Anemia Management in Peritoneal Dialysis Patients. Perit Dial Int 2008;28:76-80. [DOI: 10.1177/089686080802803s16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Richards KM, Spicer RA, Craig E, Kennedy SE. Prevalence and predictors of blood transfusion after pediatric kidney transplantation. Pediatr Nephrol 2018;33:2177-84. [PMID: 30006835 DOI: 10.1007/s00467-018-4017-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Koshy SM, Geary DF. Anemia in children with chronic kidney disease. Pediatr Nephrol. 2008;23:209-219. [PMID: 17245602 DOI: 10.1007/s00467-006-0381-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
7 Maruyama T, Higuchi T, Yamazaki T, Okawa E, Ando H, Oikawa O, Inoshita A, Okada K, Abe M. Levocarnitine Injections Decrease the Need for Erythropoiesis-Stimulating Agents in Hemodialysis Patients with Renal Anemia. Cardiorenal Med 2017;7:188-97. [PMID: 28736559 DOI: 10.1159/000462983] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
8 Metra M, Nodari S, Bordonali T, Bugatti S, Fontanella B, Lombardi C, Saporetti A, Verzura G, Danesi R, Dei Cas L. Anemia and heart failure: a cause of progression or only a consequence? Heart Int 2007;3:1. [PMID: 21977269 DOI: 10.4081/hi.2007.1] [Reference Citation Analysis]
9 Williams CE, Curtis BM, Randell EW, Foley RN, Parfrey PS. Cardiac biomarkers and health-related quality of life in new hemodialysis patients without symptomatic cardiac disease. Can J Kidney Health Dis 2014;1:16. [PMID: 26038709 DOI: 10.1186/2054-3581-1-16] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
10 Panchapakesan U, Sumual S, Pollock C. Nanomedicines in the treatment of anemia in renal disease: focus on CERA (Continuous Erythropoietin Receptor Activator). Int J Nanomedicine 2007;2:33-8. [PMID: 17722510 DOI: 10.2147/nano.2007.2.1.33] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
11 Foley RN. Target hemoglobin trials in chronic kidney disease: design and interpretation issues. Pediatr Nephrol 2009;24:2279-85. [PMID: 19221807 DOI: 10.1007/s00467-009-1123-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
12 Canney M, Birks P, Shao S, Parfrey P, Djurdjev O, Levin A. Temporal Trends in Hemoglobin, Use of Erythropoiesis Stimulating Agents, and Major Clinical Outcomes in Incident Dialysis Patients in Canada. Kidney Int Rep 2021;6:1130-40. [PMID: 33912762 DOI: 10.1016/j.ekir.2020.12.022] [Reference Citation Analysis]
13 Nassif ME, Patel JS, Shuster JE, Raymer DS, Jackups R Jr, Novak E, Gage BF, Prasad S, Silvestry SC, Ewald GA, LaRue SJ. Clinical outcomes with use of erythropoiesis stimulating agents in patients with the HeartMate II left ventricular assist device. JACC Heart Fail 2015;3:146-53. [PMID: 25660839 DOI: 10.1016/j.jchf.2014.08.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
14 Yilmaz M, Kircelli F, Artan AS, Oto O, Asci G, Gunestepe K, Basci A, Ok E, Sever MS. Naturally nonanemic dialysis patients: Who are they? Hemodial Int 2016;20:522-9. [PMID: 27147461 DOI: 10.1111/hdi.12425] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Borawski B, Malyszko JS, Kwiatkowska M, Malyszko J. Current Status of Renal Anemia Pharmacotherapy-What Can We Offer Today. J Clin Med 2021;10:4149. [PMID: 34575261 DOI: 10.3390/jcm10184149] [Reference Citation Analysis]
16 Parfrey PS. In the Literature: On Clinical Performance Measures and Outcomes Among Hemodialysis Patients. American Journal of Kidney Diseases 2007;49:352-5. [DOI: 10.1053/j.ajkd.2007.01.019] [Cited by in Crossref: 6] [Article Influence: 0.4] [Reference Citation Analysis]
17 Koulouridis I, Alfayez M, Trikalinos TA, Balk EM, Jaber BL. Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis. Am J Kidney Dis 2013;61:44-56. [PMID: 22921639 DOI: 10.1053/j.ajkd.2012.07.014] [Cited by in Crossref: 103] [Cited by in F6Publishing: 79] [Article Influence: 10.3] [Reference Citation Analysis]
18 Anker SD, Toto R. Future perspectives on treatment with erythropoiesis-stimulating agents in high-risk patients. NDT Plus 2009;2:i3-8. [PMID: 19461857 DOI: 10.1093/ndtplus/sfn174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
19 Lewis EF, Pfeffer MA, Feng A, Uno H, McMurray JJ, Toto R, Gandra SR, Solomon SD, Moustafa M, Macdougall IC. Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trial. Clin J Am Soc Nephrol. 2011;6:845-855. [PMID: 21212421 DOI: 10.2215/cjn.06450710] [Cited by in Crossref: 39] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
20 Staples AO, Wong CS, Smith JM, Gipson DS, Filler G, Warady BA, Martz K, Greenbaum LA. Anemia and risk of hospitalization in pediatric chronic kidney disease. Clin J Am Soc Nephrol 2009;4:48-56. [PMID: 19056614 DOI: 10.2215/CJN.05301107] [Cited by in Crossref: 45] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
21 Portolés J, Martín L, Broseta JJ, Cases A. Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents. Front Med (Lausanne) 2021;8:642296. [PMID: 33842503 DOI: 10.3389/fmed.2021.642296] [Reference Citation Analysis]
22 Kaze FF, Kengne AP, Djalloh AM, Ashuntantang G, Halle MP, Menanga AP, Kingue S. Pattern and correlates of cardiac lesions in a group of sub-Saharan African patients on maintenance hemodialysis. Pan Afr Med J 2014;17:3. [PMID: 25184020 DOI: 10.11604/pamj.2014.17.3.3422] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
23 Crowe K, Quinn TJ, Mark PB, Findlay MD. "Is It Removed During Dialysis?"-Cognitive Dysfunction in Advanced Kidney Failure-A Review Article. Front Neurol 2021;12:787370. [PMID: 34925220 DOI: 10.3389/fneur.2021.787370] [Reference Citation Analysis]
24 Foley RN. Treatment of anemia in chronic kidney disease: known, unknown, and both. J Blood Med 2011;2:103-12. [PMID: 22287869 DOI: 10.2147/JBM.S13066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
25 Staples A, Wong C. Risk factors for progression of chronic kidney disease. Curr Opin Pediatr 2010;22:161-9. [PMID: 20090523 DOI: 10.1097/MOP.0b013e328336ebb0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
26 Allon M. Evidence-based cardiology in hemodialysis patients. J Am Soc Nephrol 2013;24:1934-43. [PMID: 24136920 DOI: 10.1681/ASN.2013060632] [Cited by in Crossref: 32] [Cited by in F6Publishing: 7] [Article Influence: 3.6] [Reference Citation Analysis]
27 . Chapter 3: Use of ESAs and other agents to treat anemia in CKD. Kidney Int Suppl (2011) 2012;2:299-310. [PMID: 25018950 DOI: 10.1038/kisup.2012.35] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
28 Mikhail A, Brown C, Williams JA, Mathrani V, Shrivastava R, Evans J, Isaac H, Bhandari S. Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease. BMC Nephrol 2017;18:345. [PMID: 29191165 DOI: 10.1186/s12882-017-0688-1] [Cited by in Crossref: 80] [Cited by in F6Publishing: 59] [Article Influence: 16.0] [Reference Citation Analysis]
29 Shamseddin MK, Parfrey PS. Sudden cardiac death in chronic kidney disease: epidemiology and prevention. Nat Rev Nephrol. 2011;7:145-154. [PMID: 21283136 DOI: 10.1038/nrneph.2010.191] [Cited by in Crossref: 81] [Cited by in F6Publishing: 65] [Article Influence: 7.4] [Reference Citation Analysis]
30 Coronado Daza J, Martí-Carvajal AJ, Ariza García A, Rodelo Ceballos J, Yomayusa González N, Páez-Canro C, Loza Munárriz C, Urrútia G. Early versus delayed erythropoietin for the anaemia of end-stage kidney disease. Cochrane Database Syst Rev 2015;:CD011122. [PMID: 26671531 DOI: 10.1002/14651858.CD011122.pub2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
31 Johansen KL, Chertow GM. Chronic kidney disease mineral bone disorder and health-related quality of life among incident end-stage renal-disease patients. J Ren Nutr 2007;17:305-13. [PMID: 17720099 DOI: 10.1053/j.jrn.2007.06.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
32 Foley RN, Curtis BM, Parfrey PS. Hemoglobin targets and blood transfusions in hemodialysis patients without symptomatic cardiac disease receiving erythropoietin therapy. Clin J Am Soc Nephrol 2008;3:1669-75. [PMID: 18922988 DOI: 10.2215/CJN.02100508] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
33 Anand IS. Heart failure and anemia: mechanisms and pathophysiology. Heart Fail Rev 2008;13:379-86. [PMID: 18236152 DOI: 10.1007/s10741-008-9088-8] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 3.7] [Reference Citation Analysis]
34 Van Buren P, Velez RL, Vaziri ND, Zhou XJ. Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD. Int Urol Nephrol 2012;44:499-507. [PMID: 21744260 DOI: 10.1007/s11255-011-0028-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
35 Finkelstein FO, van Nooten F, Wiklund I, Trundell D, Cella D. Measurement properties of the Short Form-36 (SF-36) and the Functional Assessment of Cancer Therapy - Anemia (FACT-An) in patients with anemia associated with chronic kidney disease. Health Qual Life Outcomes 2018;16:111. [PMID: 29855366 DOI: 10.1186/s12955-018-0933-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
36 Hara T, Kimachi M, Akizawa T, Fukuhara S, Yamamoto Y. Erratum: Interdialytic Weight Gain Effects on Hemoglobin Concentration and Cardiovascular Events. Kidney Int Rep 2021;6:1999-2007. [PMID: 34307997 DOI: 10.1016/j.ekir.2021.05.016] [Reference Citation Analysis]
37 Takashima H, Maruyama T, Abe M. Significance of Levocarnitine Treatment in Dialysis Patients. Nutrients 2021;13:1219. [PMID: 33917145 DOI: 10.3390/nu13041219] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Aapro M, Gascón P, Patel K, Rodgers GM, Fung S, Arantes LH Jr, Wish J. Erythropoiesis-Stimulating Agents in the Management of Anemia in Chronic Kidney Disease or Cancer: A Historical Perspective. Front Pharmacol 2018;9:1498. [PMID: 30687083 DOI: 10.3389/fphar.2018.01498] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
39 Parfrey PS, Lauve M, Latremouille-Viau D, Lefebvre P. Erythropoietin therapy and left ventricular mass index in CKD and ESRD patients: a meta-analysis. Clin J Am Soc Nephrol 2009;4:755-62. [PMID: 19339417 DOI: 10.2215/CJN.02730608] [Cited by in Crossref: 73] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
40 Mitwalli A, Alsuwaida A, Wakeel JA, Usama S, Zainalddain N, Al Ghonaim M, Hammad D. Do diabetic dialysis patients require more or less of erythropoietin? Ann Saudi Med 2013;33:457-63. [PMID: 24188939 DOI: 10.5144/0256-4947.2013.457] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
41 Hara T, Kimachi M, Akizawa T, Fukuhara S, Yamamoto Y. Interdialytic Weight Gain Effects on Hemoglobin Concentration and Cardiovascular Events. Kidney Int Rep 2020;5:1670-8. [PMID: 33102959 DOI: 10.1016/j.ekir.2020.07.027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
42 Kido R, Akizawa T, Fukuhara S. Haemoglobin concentration and survival of haemodialysis patients before and after experiencing cardiovascular disease: a cohort study from Japanese dialysis outcomes and practice pattern study (J-DOPPS). BMJ Open 2019;9:e031476. [PMID: 31492794 DOI: 10.1136/bmjopen-2019-031476] [Reference Citation Analysis]
43 Virani SA, Khosla A, Levin A. Chronic kidney disease, heart failure and anemia. Can J Cardiol 2008;24 Suppl B:22B-4B. [PMID: 18629385 DOI: 10.1016/s0828-282x(08)71026-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
44 Olowu WA. Epidemiology, pathophysiology, clinical characteristics and management of childhood cardiorenal syndrome. World J Nephrol 2012; 1(1): 16-24 [PMID: 24175238 DOI: 10.5527/wjn.v1.i1.16] [Reference Citation Analysis]
45 Shamseddin MK, Parfrey PS. Mechanisms of the cardiorenal syndromes. Nat Rev Nephrol 2009;5:641-9. [PMID: 19786991 DOI: 10.1038/nrneph.2009.156] [Cited by in Crossref: 54] [Cited by in F6Publishing: 35] [Article Influence: 4.2] [Reference Citation Analysis]
46 Raghban A, Kirsop J, Tang WHW. Prevention of Heart Failure in Patients with Chronic Kidney Disease. Curr Cardiovasc Risk Rep 2015;9. [DOI: 10.1007/s12170-014-0428-z] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
47 Pedrini LA, Zawada AM, Winter AC, Pham J, Klein G, Wolf M, Feuersenger A, Ruggiero P, Feliciani A, Barbieri C, Gauly A, Canaud B, Stuard S. Effects of high-volume online mixed-hemodiafiltration on anemia management in dialysis patients. PLoS One 2019;14:e0212795. [PMID: 30794672 DOI: 10.1371/journal.pone.0212795] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
48 Kuo KL, Hung SC, Tseng WC, Tsai MT, Liu JS, Lin MH, Hsu CC, Tarng DC; Taiwan Society of Nephrology Renal Registry Data System. Association of Anemia and Iron Parameters With Mortality Among Patients Undergoing Prevalent Hemodialysis in Taiwan: The AIM - HD Study. J Am Heart Assoc 2018;7:e009206. [PMID: 30371224 DOI: 10.1161/JAHA.118.009206] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
49 de Francisco AL. Individualizing anaemia therapy. NDT Plus 2010;3:519-26. [PMID: 25949459 DOI: 10.1093/ndtplus/sfq164] [Reference Citation Analysis]
50 Kuo KL, Hung SC, Lee TS, Tarng DC. Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD. J Am Soc Nephrol 2014;25:2596-606. [PMID: 24722448 DOI: 10.1681/ASN.2013080838] [Cited by in Crossref: 48] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
51 Brunelli SM, Joffe MM, Israni RK, Yang W, Fishbane S, Berns JS, Feldman HI. History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patients. Clin J Am Soc Nephrol 2008;3:777-82. [PMID: 18337553 DOI: 10.2215/CJN.04281007] [Cited by in Crossref: 60] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
52 Spiegel BM, Melmed G, Robbins S, Esrailian E. Biomarkers and health-related quality of life in end-stage renal disease: a systematic review. Clin J Am Soc Nephrol. 2008;3:1759-1768. [PMID: 18832106 DOI: 10.2215/cjn.00820208] [Cited by in Crossref: 78] [Cited by in F6Publishing: 37] [Article Influence: 5.6] [Reference Citation Analysis]
53 Ye Y, Liu H, Chen Y, Zhang Y, Li S, Hu W, Yang R, Zhang Z, Lv L, Liu X. Hemoglobin targets for the anemia in patients with dialysis-dependent chronic kidney disease: a meta-analysis of randomized, controlled trials. Ren Fail 2018;40:671-9. [PMID: 30741617 DOI: 10.1080/0886022X.2018.1532909] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
54 Ookawara S, Ito K, Sasabuchi Y, Hayasaka H, Kofuji M, Uchida T, Horigome K, Imai S, Akikawa T, Wada N, Kiryu S, Imada S, Shindo M, Miyazawa H, Hirai K, Onishi Y, Shimoyama H, Watanabe A, Tabei K, Morishita Y. Associations of cerebral oxygenation with hemoglobin levels evaluated by near-infrared spectroscopy in hemodialysis patients. PLoS One 2020;15:e0236720. [PMID: 32776946 DOI: 10.1371/journal.pone.0236720] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
55 Shah AD, Nicholas O, Timmis AD, Feder G, Abrams KR, Chen R, Hingorani AD, Hemingway H. Threshold haemoglobin levels and the prognosis of stable coronary disease: two new cohorts and a systematic review and meta-analysis. PLoS Med 2011;8:e1000439. [PMID: 21655315 DOI: 10.1371/journal.pmed.1000439] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
56 Babitt JL, Lin HY. Mechanisms of anemia in CKD. J Am Soc Nephrol. 2012;23:1631-1634. [PMID: 22935483 DOI: 10.1681/asn.2011111078] [Cited by in Crossref: 352] [Cited by in F6Publishing: 194] [Article Influence: 35.2] [Reference Citation Analysis]
57 Nishiwaki H, Hasegawa T, Koiwa F, Hamano T, Masakane I. The association of the difference in hemoglobin levels before and after hemodialysis with the risk of 1-year mortality in patients undergoing hemodialysis. Results from a nationwide cohort study of the Japanese Renal Data Registry. PLoS One 2019;14:e0210533. [PMID: 30629677 DOI: 10.1371/journal.pone.0210533] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Staibano P, Perelman I, Lombardi J, Davis A, Tinmouth A, Carrier M, Stevenson C, Saidenberg E. Patient-Centred Outcomes in Anaemia and Renal Disease: A Systematic Review. Kidney Dis (Basel) 2020;6:74-84. [PMID: 32309289 DOI: 10.1159/000502208] [Reference Citation Analysis]
59 Song HY, Wei CM, Zhou WX, Hu HF, Wan QJ. Association between admission hemoglobin level and prognosis in patients with type 2 diabetes mellitus. World J Diabetes 2021; 12(11): 1917-1927 [PMID: 34888016 DOI: 10.4239/wjd.v12.i11.1917] [Reference Citation Analysis]
60 Thamer M, Zhang Y, Lai D, Kshirsagar O, Cotter D. Influence of safety warnings on ESA prescribing among dialysis patients using an interrupted time series. BMC Nephrol 2013;14:172. [PMID: 23927675 DOI: 10.1186/1471-2369-14-172] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
61 Marshall MR, Vandal AC, de Zoysa JR, Gabriel RS, Haloob IA, Hood CJ, Irvine JH, Matheson PJ, McGregor DOR, Rabindranath KS, Schollum JBW, Semple DJ, Xie Z, Ma TM, Sisk R, Dunlop JL. Effect of Low-Sodium versus Conventional Sodium Dialysate on Left Ventricular Mass in Home and Self-Care Satellite Facility Hemodialysis Patients: A Randomized Clinical Trial. J Am Soc Nephrol 2020;31:1078-91. [PMID: 32188697 DOI: 10.1681/ASN.2019090877] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 4.5] [Reference Citation Analysis]
62 Kuo KL, Hung SC, Lin YP, Tang CF, Lee TS, Lin CP, Tarng DC. Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients. PLoS One 2012;7:e50295. [PMID: 23227165 DOI: 10.1371/journal.pone.0050295] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 4.7] [Reference Citation Analysis]
63 Covic A, Gusbeth-Tatomir P, Goldsmith DJ. The epidemics of cardiovascular disease in elderly patients with chronic kidney disease--two facets of the same problem. Int Urol Nephrol 2006;38:371-9. [PMID: 16868714 DOI: 10.1007/s11255-006-0044-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
64 Jing Z, Wei-jie Y, Nan Z, Yi Z, Ling W. Hemoglobin targets for chronic kidney disease patients with anemia: a systematic review and meta-analysis. PLoS One 2012;7:e43655. [PMID: 22952731 DOI: 10.1371/journal.pone.0043655] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
65 Jablonski KL, Chonchol M. Recent advances in the management of hemodialysis patients: a focus on cardiovascular disease. F1000Prime Rep 2014;6:72. [PMID: 25165571 DOI: 10.12703/P6-72] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
66 Baglin A, Hanslik T, Prinseau J, Moulonguet-doleris L. Érythropoïétine et insuffisance rénale : jusqu’où ne pas aller ? La Revue de Médecine Interne 2008;29:846-51. [DOI: 10.1016/j.revmed.2007.10.415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
67 McMahon LP, Cai MX, Baweja S, Holt SG, Kent AB, Perkovic V, Leikis MJ, Becker GJ. Mortality in dialysis patients may not be associated with ESA dose: a 2-year prospective observational study. BMC Nephrol 2012;13:40. [PMID: 22702540 DOI: 10.1186/1471-2369-13-40] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
68 Guedes M, Guetter CR, Erbano LHO, Palone AG, Zee J, Robinson BM, Pisoni R, de Moraes TP, Pecoits-Filho R, Baena CP. Physical health-related quality of life at higher achieved hemoglobin levels among chronic kidney disease patients: a systematic review and meta-analysis. BMC Nephrol 2020;21:259. [PMID: 32641153 DOI: 10.1186/s12882-020-01912-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Maruyama Y, Yokoyama K, Yokoo T, Shigematsu T, Iseki K, Tsubakihara Y. The Different Association between Serum Ferritin and Mortality in Hemodialysis and Peritoneal Dialysis Patients Using Japanese Nationwide Dialysis Registry. PLoS One 2015;10:e0143430. [PMID: 26599216 DOI: 10.1371/journal.pone.0143430] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
70 Moreno López R, Sicilia Aladrén B, Gomollón García F. Use of agents stimulating erythropoiesis in digestive diseases. World J Gastroenterol 2009; 15(37): 4675-4685 [PMID: 19787831 DOI: 10.3748/wjg.15.4675] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
71 Foley RN, Curtis BM, Randell EW, Parfrey PS. Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease. Clin J Am Soc Nephrol. 2010;5:805-813. [PMID: 20378644 DOI: 10.2215/cjn.07761109] [Cited by in Crossref: 87] [Cited by in F6Publishing: 42] [Article Influence: 7.3] [Reference Citation Analysis]
72 Coyne DW. The health-related quality of life was not improved by targeting higher hemoglobin in the Normal Hematocrit Trial. Kidney Int 2012;82:235-41. [PMID: 22437411 DOI: 10.1038/ki.2012.76] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 5.7] [Reference Citation Analysis]
73 Akizawa T, Nangaku M, Yamaguchi T, Arai M, Koretomo R, Maeda K, Miyazawa Y, Hirakata H. Enarodustat, Conversion and Maintenance Therapy for Anemia in Hemodialysis Patients: A Randomized, Placebo-Controlled Phase 2b Trial Followed by Long-Term Trial. Nephron 2019;143:77-85. [PMID: 31117088 DOI: 10.1159/000500487] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
74 Bonato FO, Lemos MM, Cassiolato JL, Canziani ME. Prevalence of ventricular arrhythmia and its associated factors in nondialyzed chronic kidney disease patients. PLoS One 2013;8:e66036. [PMID: 23762460 DOI: 10.1371/journal.pone.0066036] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
75 Eckardt KU, Scherhag A, Macdougall IC, Tsakiris D, Clyne N, Locatelli F, Zaug MF, Burger HU, Drueke TB. Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in CKD. J Am Soc Nephrol 2009;20:2651-60. [PMID: 19850955 DOI: 10.1681/ASN.2009060631] [Cited by in Crossref: 81] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
76 Hahn D, Cody JD, Hodson EM. Frequency of administration of erythropoiesis-stimulating agents for the anaemia of end-stage kidney disease in dialysis patients. Cochrane Database Syst Rev 2014;:CD003895. [PMID: 24872328 DOI: 10.1002/14651858.CD003895.pub3] [Cited by in Crossref: 6] [Article Influence: 0.8] [Reference Citation Analysis]
77 Hörl WH. Anaemia management and mortality risk in chronic kidney disease. Nat Rev Nephrol 2013;9:291-301. [PMID: 23438972 DOI: 10.1038/nrneph.2013.21] [Cited by in Crossref: 66] [Cited by in F6Publishing: 55] [Article Influence: 7.3] [Reference Citation Analysis]
78 Sagheb MM, Fallahzadeh MA, Moaref A, Fallahzadeh MH, Dormanesh B. Comparison of Hemoglobin Levels Before and After Hemodialysis and Their Effects on Erythropoietin Dosing and Cost. Nephrourol Mon 2016;8:e38495. [PMID: 27713870 DOI: 10.5812/numonthly.38495] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
79 Silverberg DS, Wexler D, Iaina A, Steinbruch S, Wollman Y, Schwartz D. Anemia, chronic renal disease and congestive heart failure--the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists. Int Urol Nephrol. 2006;38:295-310. [PMID: 16868702 DOI: 10.1007/s11255-006-0064-8] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 4.3] [Reference Citation Analysis]
80 Toida T, Iwakiri T, Sato Y, Komatsu H, Kitamura K, Fujimoto S. Relationship between Hemoglobin Levels Corrected by Interdialytic Weight Gain and Mortality in Japanese Hemodialysis Patients: Miyazaki Dialysis Cohort Study. PLoS One 2017;12:e0169117. [PMID: 28046068 DOI: 10.1371/journal.pone.0169117] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
81 Foley RN. Erythropoietin: physiology and molecular mechanisms. Heart Fail Rev 2008;13:405-14. [PMID: 18236154 DOI: 10.1007/s10741-008-9083-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
82 Jung MY, Hwang SY, Hong YA, Oh SY, Seo JH, Lee YM, Park SW, Kim JS, Wang JK, Kim JY, Lee JE, Ko GJ, Pyo HJ, Kwon YJ. Optimal hemoglobin level for anemia treatment in a cohort of hemodialysis patients. Kidney Res Clin Pract 2015;34:20-7. [PMID: 26484015 DOI: 10.1016/j.krcp.2014.11.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
83 Palmer SC, Saglimbene V, Mavridis D, Salanti G, Craig JC, Tonelli M, Wiebe N, Strippoli GF. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis. Cochrane Database Syst Rev 2014;:CD010590. [PMID: 25486075 DOI: 10.1002/14651858.CD010590.pub2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
84 Sumida K, Diskin CD, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Rhee CM, Streja E, Yamagata K, Kalantar-Zadeh K, Kovesdy CP. Pre-End-Stage Renal Disease Hemoglobin Variability Predicts Post-End-Stage Renal Disease Mortality in Patients Transitioning to Dialysis. Am J Nephrol 2017;46:397-407. [PMID: 29130991 DOI: 10.1159/000484356] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
85 Lee SH, Kim M, Han KD, Lee JH. Low hemoglobin levels and an increased risk of psoriasis in patients with chronic kidney disease. Sci Rep 2021;11:14741. [PMID: 34285267 DOI: 10.1038/s41598-021-94165-w] [Reference Citation Analysis]
86 Mc Causland FR, Claggett B, Burdmann EA, Chertow GM, Cooper ME, Eckardt KU, Ivanovich P, Levey AS, Lewis EF, McGill JB, McMurray JJV, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto RD, Pfeffer MA. Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). Am J Kidney Dis 2019;73:309-15. [PMID: 30578152 DOI: 10.1053/j.ajkd.2018.10.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
87 Schneider A, Drechsler C, Krane V, Krieter DH, Scharnagl H, Schneider MP, Wanner C; MINOXIS Study Investigators. The effect of high-flux hemodialysis on hemoglobin concentrations in patients with CKD: results of the MINOXIS study. Clin J Am Soc Nephrol 2012;7:52-9. [PMID: 22096040 DOI: 10.2215/CJN.02710311] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
88 Biggar P, Kim GH. Treatment of renal anemia: Erythropoiesis stimulating agents and beyond. Kidney Res Clin Pract 2017;36:209-23. [PMID: 28904872 DOI: 10.23876/j.krcp.2017.36.3.209] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]